-- Illumina (ILMN) 和生物医学数据驱动发现中心 (D3b) 周二宣布，双方已启动数据合作，旨在推进儿童癌症和罕见病的研究。 根据该合作计划，D3b 将使用 Illumina 的软件分析 10 万名儿童患者的全基因组，构建一个统一的基因组数据集。 两家公司表示，这些数据将通过 Gabriella Miller 儿童优先数据资源中心 (Gabriella Miller Kids First Data Resource Center) 提供，以支持研究和临床见解。 该数据集将包含通过联邦资助项目（包括儿童脑肿瘤网络）收集的罕见先天性疾病和癌症患者的基因组。 根据一份联合声明，Illumina 还将加入美国卫生高级研究计划署 (ARPA) 的儿科护理扩展计划 (Pediatric Care eXpansion program)，该计划旨在通过扩大美国 200 多家儿科机构的数据共享，加速诊断和治疗。
Price: $129.43, Change: $+2.47, Percent Change: +1.95%
FINEOS (ASX:FCL) reported first-quarter customer cash receipts of 56.5 million euros, up 9.3% year-on-year, driven by subscription fee revenues invoiced in January, according to a Monday Australian bourse filing.The company recorded customer cash receipts of 51.7 million euros for the three months ending March 31, 2025, an earlier filing showed.Exchange rate movements during the quarter had a positive impact of 1 million euros on the cash balance.The company's full-year revenue guidance remains in the range of 147 million euros to 152 million euros.The company's shares fell 1% in recent Monday trade.
Changyu Holding (SHA:603407) priced its initial public offering on the Shanghai Stock Exchange of 41 million shares at 13.86 yuan apiece to raise 568.3 million yuan, according to a weekend filing on the bourse.Proceeds will be invested in the company's zirconium oxychloride and deep-processing project, a nylon elastomer products project, and a bioceramics and functional ceramics products project.
Shaanxi Coal Industry's (SHA:601225) net profit attributable to shareholders in 2025 dropped 25% year on year to 16.8 billion yuan, or 1.73 yuan per share, according to a Saturday filing on the Shanghai bourse.The coal miner's share dropped 4% during the morning trade.The attributable profit a year earlier was 22.4 billion yuan, or 2.31 yuan per share.Operating revenue fell 14% to 158.2 billion yuan from 184.1 billion yuan in the previous year.